Development of a CTL vaccine for Her-2/neu using peptide-microspheres and adjuvants.
- DOI
- 10.1016/j.vaccine.2005.01.149
- Published
- 2005 May 20
- Container
- Vaccine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.vaccine.2005.01.149,
title = {Development of a CTL vaccine for Her-2/neu using peptide-microspheres and adjuvants.},
author = {Mossman SP and Evans LS and Fang H and Staas J and Tice T and Raychaudhuri S and Grabstein KH and Cheever MA and Johnson ME},
year = {2005},
journal = {Vaccine},
doi = {10.1016/j.vaccine.2005.01.149},
url = {https://doi.org/10.1016/j.vaccine.2005.01.149}
}RIS
TY - JOUR TI - Development of a CTL vaccine for Her-2/neu using peptide-microspheres and adjuvants. AU - Mossman SP AU - Evans LS AU - Fang H AU - Staas J AU - Tice T AU - Raychaudhuri S AU - Grabstein KH AU - Cheever MA AU - Johnson ME PY - 2005 JO - Vaccine DO - 10.1016/j.vaccine.2005.01.149 UR - https://doi.org/10.1016/j.vaccine.2005.01.149 ER -
APA
SP, M., LS, E., H, F., J, S., T, T., S, R., KH, G., MA, C., & ME, J. (2005). Development of a CTL vaccine for Her-2/neu using peptide-microspheres and adjuvants.. Vaccine. https://doi.org/10.1016/j.vaccine.2005.01.149
Source records
- pubmed · retrieved 2026-09-26T07:27:45.349Z